| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/28/2001 | EP1078256A1 Process for evaluating chemical and biological assays |
| 02/28/2001 | EP1078249A1 Scanning system and method of operation for automatically setting detection sensitivity |
| 02/28/2001 | EP1078243A1 Optical spectroscopy sample cell |
| 02/28/2001 | EP1078241A1 Method for analyzing total reactive sulfur |
| 02/28/2001 | EP1078230A1 Apparatus and method for measuring exhaust gas emissions |
| 02/28/2001 | EP1078104A1 Demonstrating resistance to antibiotics in microorganisms |
| 02/28/2001 | EP1078098A1 Method and probes for the detection of chromosome aberrations |
| 02/28/2001 | EP1078086A2 Plant-derived resistance gene |
| 02/28/2001 | EP1078078A1 Complex formed by a peptide and a major histocompatibility complex at the surface of phages |
| 02/28/2001 | EP1078073A1 Chitinase chitin-binding fragments |
| 02/28/2001 | EP1078072A1 New peptide fragments for protein purification |
| 02/28/2001 | EP1078064A2 Compounds from moraxella catarrhalis |
| 02/28/2001 | EP1078063A2 Basb029polynucleotide(s) and polypeptides from neisseria meningitis |
| 02/28/2001 | EP1078060A2 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 02/28/2001 | EP1078057A2 Cell signaling proteins |
| 02/28/2001 | EP1078056A1 Rhotekin, a putative target for rho |
| 02/28/2001 | EP1078040A1 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors |
| 02/28/2001 | EP1078039A2 Method for carrying out a measurement of the interaction of chemicals with cells |
| 02/28/2001 | EP1078023A1 Luminescent compounds |
| 02/28/2001 | EP1078006A1 Diagnosis and treatment of hepatic disorders |
| 02/28/2001 | EP1077999A2 Moraxella catharralis proteins |
| 02/28/2001 | EP1077998A1 Labelled glutamine and lysine analogues |
| 02/28/2001 | EP1077997A2 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins |
| 02/28/2001 | EP1077996A1 HUMAN EDG3sb GENE |
| 02/28/2001 | EP1077993A1 Generation of combinatorial libraries of compounds corresponding to virtual libraries of compounds |
| 02/28/2001 | EP1077983A2 Pria |
| 02/28/2001 | EP1077770A1 Sample introduction device |
| 02/28/2001 | EP1077724A2 Methods and products related to metabolic interactions in disease |
| 02/28/2001 | EP1077642A1 Measuring nitric oxide concentration in tissue |
| 02/28/2001 | EP1077636A1 Signal processing for measurement of physiological analytes |
| 02/28/2001 | EP0835325B1 In vitro test procedure for detecting chemically-induced embryotoxic and teratogenic effects |
| 02/28/2001 | EP0672142B1 Multivalent and multispecific binding proteins, their manufacture and use |
| 02/28/2001 | EP0594710B1 Tyrosine kinase |
| 02/28/2001 | EP0548165B1 Expression of g protein coupled receptors in yeast |
| 02/28/2001 | EP0429611B1 Aminoalkyl maleimides and haptene and antigen derivatives thereof and conjugates with peptides or proteins |
| 02/28/2001 | CN2421652Y Multinomial synchronous enzyme immune percolator |
| 02/28/2001 | CN2421651Y Device for testing oil drop content in water |
| 02/28/2001 | CN1285918A Neutrality for polycation used in chromatographic apparatus of whole blood |
| 02/28/2001 | CN1285917A Method comprising capture molecule fixed on disc surface |
| 02/28/2001 | CN1285914A Metal oxide sensor for detecting nitrogen oxides |
| 02/28/2001 | CN1285913A Reflextometer |
| 02/28/2001 | CN1285912A Device, method and apparatus for implementing the method, for dosing at least a partucular constituent in a product sample |
| 02/28/2001 | CN1285879A Enzyme-specific cleavable polynucleotide substrate and assay method |
| 02/28/2001 | CN1285874A Desaturase genes and their use |
| 02/28/2001 | CN1285846A Detection systems for registering protein interactions and functional relationships |
| 02/28/2001 | CN1285818A Compound for antemortem diagnosis of alzheimer's disease and i(IN VIVO) imaging and prevention of amyloid deposition |
| 02/28/2001 | CN1285745A Application of enzyme products as anti-infective agents |
| 02/28/2001 | CN1285514A Medicine box bof testing anti-hepatitis C virus antibody |
| 02/28/2001 | CN1285513A Method for testing or determining HCV core antigen and the agent for same |
| 02/28/2001 | CN1285512A Method and apparatus for separating shaped compositions from composition of complex biological liquid sample |
| 02/28/2001 | CN1062662C Process for preparing human immunodeficiency virus and hapatitis C virus antibody united diagnostic reagent |
| 02/28/2001 | CN1062555C Substituted benzyloxy carbonyl guanidine, its prepn. method, and application of the same as medicament and medicament containing the same |
| 02/28/2001 | CA2314546A1 Flow-through assay for visually detecting the presence of influenza a and b |
| 02/27/2001 | US6195451 Transformation of digital images |
| 02/27/2001 | US6195158 Apparatus and method for rapid spectrophotometric pre-test screen of specimen for a blood analyzer |
| 02/27/2001 | US6194563 Solid phase nucleic acid labeling by transamination |
| 02/27/2001 | US6194561 Oligonucleotide probes of defined nucleotide sequences which are complementary to second exon of class ii hla beta chain gene; diagnosis of susceptibility to insulin-dependent diabetes mellitus and pemphigus vulgaris; antidiabetic agents |
| 02/27/2001 | US6194552 Masking antitope of antibody with orientation directing agent to form complex, then immobilizing complex on support so that antitope is oriented away from support; improved binding efficiency |
| 02/27/2001 | US6194550 Synthesizing nucleic acid mixture including messenger rna, synthesizing mixture of nucleic acid*polypeptide conjugate (copolymer) which does not contain ribosome, then partitioning by affinity to a target molecule |
| 02/27/2001 | US6194549 Partially purified preparation of pen5, a glycoprotein pair; for detecting and/or removing natural killer cells from a mixed population of cells |
| 02/27/2001 | US6194544 Cyclic semi-random peptide libraries |
| 02/27/2001 | US6194542 Method of detecting cytomegalovirus (CMV) |
| 02/27/2001 | US6194394 Coagulation controls for prothrombin time (PT) and activated partial thromboplastin time (APTT) assays |
| 02/27/2001 | US6194225 Immunochromatography-assisted device |
| 02/27/2001 | US6194224 Liquid flow is more uniform when sodium myristol sarcosinate surfactant is used in the sample receiving zone |
| 02/27/2001 | US6194223 Method for the simultaneous determination of biomolecular interactions by means of plasmon resonance and fluoresence detection |
| 02/27/2001 | US6194222 Having first labeled member of binding pair in reaction chamber and second member bound to solid support in diagnostic lane, detecting signal from lane, and determining rate of flow of solution through the assay device |
| 02/27/2001 | US6194221 Hybrid one-step immunochromatographic device and method of use |
| 02/27/2001 | US6194220 Non-instrumented assay with quantitative and qualitative results |
| 02/27/2001 | US6194219 Adding insoluble particles and an aqueous solution of boric acid to reagent liquid; when reagent is applied to a film and dried the particles and boric acid form a single coating layer |
| 02/27/2001 | US6194218 Buffer for stabilizing blood samples; mixture of sodium tetraborate and/or potassium tetraborate and potassium cyanide and/or sodium cyanide in carbon-monoxide containing water |
| 02/27/2001 | US6194217 Method of diagnosing or categorizing disorders from biochemical profiles |
| 02/27/2001 | US6194216 Isolating additive from sample, placing into cuvette, exposing to ultraviolet light, and measuring count value of fluorescence spectrum at its peak using a spectrometer |
| 02/27/2001 | US6194214 Plasma having 62.5 mg/l of annexins added to suitable matrix; prolongs clotting time in activated partial thromoplastin time; diagnosis |
| 02/27/2001 | US6194213 Lipophilic, functionalized nanocrystals and their use for fluorescence labeling of membranes |
| 02/27/2001 | US6194209 Systems and methods for standardizing herbal extracts utilizing absorption studies |
| 02/27/2001 | US6194206 Use of oligonucleotide telomerase inhibitors to reduce telomere length |
| 02/27/2001 | US6194204 Enrichment of dendritic cells from blood |
| 02/27/2001 | US6194184 Comprising the reaction product of a compound having at least one histidine group such as an antibody, enzyme, or nucleic acid, and potassium tetrathiocyanatopalladate (ii); for use in assays |
| 02/27/2001 | US6194183 Preparing polypeptide for use in surfactants; providing transformed phage, incubate with surfactants to deactivate polypeptide, separate phage that display variant polypeptides, isolated phage sequences of variant and determine sequence |
| 02/27/2001 | US6194171 Also vectors, transformed cells; useful for expression in cells for the purposes of identifying agonists or antagonists of ataxin-2-binding protein function |
| 02/27/2001 | US6194165 Cell fixative and preparation composition, kit and method |
| 02/27/2001 | US6194164 Method for quantitating cholesterol present in low density lipoproteins |
| 02/27/2001 | US6194163 Method for the quantitative measurement of human acute phase serum amyloid A protein; recombinant protein; specific antibody |
| 02/27/2001 | US6194161 Staphylococcus aureus antigen |
| 02/27/2001 | US6194160 Systems and methods for rapid blot screening |
| 02/27/2001 | US6194152 Nucleotide sequences for the diagnosis and treatment of human urogenital cancers |
| 02/27/2001 | US6194151 Nucleotide sequences coding binding polypeptide; for the detection of modulators of tumor necrosis factor activity; for the treatment of cell proliferation and differentiation defects |
| 02/27/2001 | US6194148 Method for detecting a hybridized nucleic acid molecule |
| 02/27/2001 | US6194142 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2, and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
| 02/27/2001 | US6194141 Detecting modulator of viral propagation; incubate viral nucleotide sequence mixture with metals, incubate second mixture with modulator, calibrate and compare amount of uridine incorporated into transcripts in both mixtures |
| 02/27/2001 | US6193982 Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120 |
| 02/27/2001 | US6193981 Methods and compositions for impairing multiplication of HIV-1 |
| 02/27/2001 | US6193967 Administering bispecific molecule, comprising: binding specificity for human high density lipoprotein (hdl), or fragment and for an fc.gamma. receptor for immunoglobulin g for treating and prophylaxis of atherosclerosis |
| 02/27/2001 | US6193966 Administering bispecific protein or peptide molecule, comprising a first binding determinate which binds to fc.alpha.receptor without being blocked by immunoglobulin a and second binding determinant which binds to target antigen |
| 02/27/2001 | US6193965 Administering therapeutically effective amount of reagent which modulates kinase activity for treating cell proliferative disorder associated with c-jun n-terminal kinase disorder, |
| 02/27/2001 | US6193963 Method of treating tumor-bearing patients with human plasma hyaluronidase |
| 02/27/2001 | US6193949 Method of sire selection using naloxone challenge tests and kits thereof |
| 02/27/2001 | US6193873 Sample detection to initiate timing of an electrochemical assay |
| 02/27/2001 | US6193866 Separation of charged particles by a spatially and temporally varying electric field |